276 filings
Page 2 of 14
6-K
qc45nb98c qn5an96
16 Oct 23
Update Regarding Pfizer’s Statement on COMIRNATY-Related Write-Offs
6:03am
6-K
9wfxi6nzpsnflxlzon6n
11 Sep 23
Current report (foreign)
4:03pm
6-K
hm3x7m4e em8
30 Aug 23
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union
4:12pm
6-K
woaus5rb
14 Aug 23
BioNTech Expands Management Board by Appointing James Ryan as Chief Legal Officer
8:34am
6-K
6a7vawr2by
7 Aug 23
Current report (foreign)
8:02am
6-K
widh9b68h2de
7 Aug 23
BioNTech Announces Second Quarter 2023 Financial Results and Corporate Update
6:06am
6-K
qq1req
31 Jul 23
BioNTech Completes Acquisition of InstaDeep
8:12am
6-K
3e5 71h68x
29 Jun 23
Current report (foreign)
7:09am
6-K
cswj7um6bk1p95a9yv72
26 Jun 23
Current report (foreign)
5:26pm
6-K
vkbt7hevtqt
23 Jun 23
Current report (foreign)
4:41pm
6-K
vct s5tt7o7vlmre
2 Jun 23
BioNTech and OncoC4 Present Positive Phase 1/2 Data for Antibody Candidate BNT316/ONC-392 in Hard-to-Treat NSCLC at ASCO
8:51am
6-K
upxu tseb
2 Jun 23
Current report (foreign)
8:48am
6-K
7o4gr ronn
26 May 23
Pfizer and BioNTech Provide Update on COVID-19 Vaccine Supply Agreement with the European Commission
7:43am
6-K
rop4c9w
25 May 23
Changes in the Supervisory Board of BioNTech SE and Voting Results from the Annual General Meeting 2023
4:06pm
6-K
hio5r4fh9itl04
8 May 23
Current report (foreign)
9:22am
6-K
ewcurfxayoz kt
8 May 23
Current report (foreign)
6:56am
6-K
va836y tba
8 May 23
BioNTech Announces First Quarter 2023 Financial Results and Corporate Update
6:53am
6-K
yyn1m94me 27
13 Apr 23
Invitation to the Annual General Meeting 2023
4:25pm
6-K
ue8vo1 5gq0jlh
3 Apr 23
Current report (foreign)
8:07am
6-K
jgcnl4o
28 Mar 23
BioNTech Announces New ADS Repurchase Program
6:59am